Filter
366
Text search:
guidelines
for
pharmacovigilance
Featured
46
112
Language
Document type
176
71
44
34
25
7
4
3
1
1
Countries / Regions
22
15
14
13
13
13
13
11
10
9
9
8
8
7
7
7
5
5
5
5
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
189
41
9
8
6
6
6
Toolboxes
45
44
32
30
21
17
14
5
2
2
2
1
1
1
1
1
1
Interim policy guidance
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid,
...
Accessed November 2017
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported
...
Documentation of Best Practices and Bottlenecks to Program Implementation in Senegal
SUMMARY REPORT
Accessed at March 2014
2014-2020, Draft March 2014
Master of Science in Pharmaceutical Management Dissertation
Celebrating ten years of success 2004-2014
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
8–18 December 2015
